+62.6%
GSK vs DRI
+66.4%
-3.8%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | DRI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -1.0% | +0.9% | 0.0% |
| 7D | +1.7% | +2.8% | -1.2% | +1.2% |
| 30D | +7.0% | +13.3% | -6.2% | +5.0% |
| 3M | -2.7% | +8.2% | -10.8% | -4.0% |
| 6M | +1.4% | +17.5% | -16.1% | -1.2% |
| YTD | +5.3% | +26.9% | -21.6% | +1.7% |
| 1Y | +10.6% | +31.6% | -20.9% | +6.4% |
| 3Y | +62.6% | +67.0% | -4.4% | +54.8% |
| All | +62.6% | +66.4% | -3.8% | +54.8% |
Cumulative growth
Daily Returns
Daily percentage return beside DRI.
Daily Out/Under-Performance
Portfolio return minus DRI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DRI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded DRI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling